Related Experiment Videos
[4 Cases of malignant mesenteric tumor]
Gan No Rinsho. Japan Journal of Cancer Clinics
|January 1, 1984
Summary
Malignant mesenteric tumors require prompt surgical removal and chemotherapy for effective treatment. Early diagnosis via CT scans and GI series is crucial for initiating timely intervention and improving patient outcomes.
Area of Science:
- Oncology
- Surgical Oncology
- Gastrointestinal Oncology
Background:
- Mesenteric tumors are rare neoplasms originating from the mesentery, a fold of peritoneum that attaches the intestines to the posterior abdominal wall.
- Malignant mesenteric tumors encompass a range of rare cancers, including non-Hodgkin's lymphoma, leiomyosarcoma, and fibrosarcoma, posing significant diagnostic and therapeutic challenges.
Observation:
- This case series presents four male patients diagnosed with malignant mesenteric tumors, varying in age from 35 to 81 years.
- Histopathological diagnoses included non-Hodgkin's lymphoma, leiomyosarcoma, and well-differentiated fibrosarcoma.
- Treatment modalities ranged from radical surgical excision to exploratory laparotomy, with one patient diagnosed posthumously.
Findings:
- Radical excision was performed on three patients with non-Hodgkin's lymphoma, leiomyosarcoma, and fibrosarcoma.
- The fourth patient, diagnosed with leiomyosarcoma, underwent only exploratory laparotomy and was subsequently studied postmortem.
- The findings underscore the aggressive nature of these tumors and the varied responses to treatment.
Implications:
- Early diagnosis of mesenteric tumors using imaging techniques like CT scans and GI series is paramount.
- A combined approach of surgical resection and chemotherapy is recommended for optimal management of malignant mesenteric tumors.
- Further research into multimodal treatment strategies is warranted to improve survival rates for patients with these rare malignancies.